KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Colgate Palmolive (CL) over the last 16 years, with Dec 2024 value amounting to $1.1 billion.

  • Colgate Palmolive's Cash & Equivalents rose 3.65% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 3.65%. This contributed to the annual value of $1.1 billion for FY2024, which is 13.46% up from last year.
  • Per Colgate Palmolive's latest filing, its Cash & Equivalents stood at $1.1 billion for FY2024, which was up 13.46% from $966.0 million recorded in FY2023.
  • Colgate Palmolive's Cash & Equivalents' 5-year high stood at $1.1 billion during FY2024, with a 5-year trough of $775.0 million in FY2022.
  • Its 3-year average for Cash & Equivalents is $945.7 million, with a median of $966.0 million in 2023.
  • In the last 5 years, Colgate Palmolive's Cash & Equivalents dropped by 6.85% in 2022 and then climbed by 24.65% in 2023.
  • Over the past 5 years, Colgate Palmolive's Cash & Equivalents (Yearly) stood at $888.0 million in 2020, then dropped by 6.31% to $832.0 million in 2021, then declined by 6.85% to $775.0 million in 2022, then rose by 24.65% to $966.0 million in 2023, then rose by 13.46% to $1.1 billion in 2024.